---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-028572"
form_type: "8-K"
ticker: "MBRX"
cik: "0001659617"
company_name: "Moleculin Biotech, Inc."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-28T19:48:46.047269+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Moleculin Biotech posts corporate presentation; no material new information extractable from filing

## Summary
- Investor presentation dated September 2025 posted on company website, but exhibit is an image file with no extractable text.
- Filing contains no new revenue, clinical trial results, guidance changes, or other material operational updates.
- Presentation likely includes overview of pipeline and strategy; specific content cannot be verified from the 8-K filing alone.

## SEC filing metadata
- accession: 0001437749-25-028572
- form_type: 8-K
- ticker: MBRX
- cik: 0001659617
- company_name: Moleculin Biotech, Inc.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1659617/000143774925028572/0001437749-25-028572-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1659617/000143774925028572/mbrx20250908_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-028572
- JSON: https://secwatch.observer/filing/0001437749-25-028572.json
- Plain text: https://secwatch.observer/filing/0001437749-25-028572.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.